XML 66 R46.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Debt (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Debt Disclosure [Abstract] |
Schedule of Short-Term and Long-Term Debt Obligations | The following table summarizes the Company’s short-term and long-term debt obligations as of December 31, 2024 and 2023:
Lender |  | Borrower |  | Line of Credit |  | Term |  | Maturity Date |  | Interest Rate |  | As of December 31,
2024 |  | 2023
|  |  |  |  |  |  |  |  |  |  |  | $ |  | RMB |  | $ |  | RMB
China Construction Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB580,000 |  | 9-year |  | June 11, 2027 |  | 1 |  | 16,440 |  |  | 120,000 |  |  | 14,089 |  |  | 100,000 |
China Merchants Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB350,000 |  | 9-year |  | January 20, 2029 |  | 2 |  | 8,611 |  |  | 62,857 |  |  | 8,856 |  |  | 62,857 |
China Merchants Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB378,000 |  | 9-year |  | November 8, 2029 |  | 3 |  | 8,148 |  |  | 59,475 |  |  | 5,636 |  |  | 40,000 |
China CITIC Bank |  | BeiGene (Suzhou) Co., Ltd. |  | RMB480,000 |  | 10-year |  | July 28, 2032 |  | 4 |  | 1,384 |  |  | 10,100 |  |  | — |  |  | — |
China Merchants Bank |  | BeiGene, Ltd. |  | $380,000 |  | 1-year |  | 5 |  | 380,000 |  |  | 2,773,723 |  |  | 300,000 |  |  | 2,129,321 |
China Minsheng Bank |  | BeiGene, Ltd. |  | $150,000 |  | 1-year |  | December 16, 2025 |  | 6.8% |  | 150,000 |  |  | 1,094,891 |  |  | 150,000 |  |  | 1,064,660 |
China Industrial Bank |  | BeiGene, Ltd. |  | RMB675,000 |  | 364-days |  | March 27, 2025 |  | 6 |  | 92,475 |  |  | 675,000 |  |  | — |  |  | — |
China Merchants Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB400,000 |  | 1-year |  | June 5, 2025 |  | 3.0% |  | 54,800 |  |  | 400,000 |  |  | 56,356 |  |  | 400,000 |
HSBC Bank |  | BeiGene, Ltd. |  | RMB340,000 |  | 1-year |  | May 5, 2025 |  | 7 |  | 46,580 |  |  | 340,000 |  |  | 47,903 |  |  | 340,000 |
China Industrial Bank |  | BeiGene (Suzhou) Co., Ltd. |  | RMB200,000 |  | 1-year |  | May 29, 2024 |  | 2.8% |  | — |  |  | — |  |  | 28,177 |  |  | 200,000 |
Shanghai Pudong Development Bank |  | BeiGene, Ltd. |  | RMB700,000 |  | 1-year |  | November 24, 2025 |  | 2.9% |  | 93,091 |  |  | 679,492 |  |  | 49,312 |  |  | 350,000 |
China Merchants Bank |  | BeiGene (Suzhou) Co., Ltd. |  | RMB200,000 |  | 1-year |  | May 24, 2024 |  | 3.2% |  | — |  |  | — |  |  | 28,037 |  |  | 199,000 |
Total short-term debt |  | 851,529 |  |  | 6,215,538 |  |  | 688,366 |  |  | 4,885,838 |
China Construction Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB580,000 |  | 9-year |  | June 11, 2027 |  | 1 |  | 41,100 |  |  | 300,000 |  |  | 59,174 |  |  | 420,000 |
China Merchants Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB350,000 |  | 9-year |  | January 20, 2029 |  | 2 |  | 27,987 |  |  | 204,286 |  |  | 37,638 |  |  | 267,143 |
China Merchants Bank |  | BeiGene Guangzhou Biologics Manufacturing Co., Ltd. |  | RMB378,000 |  | 9-year |  | November 8, 2029 |  | 3 |  | 33,020 |  |  | 241,025 |  |  | 42,337 |  |  | 300,500 |
China CITIC Bank |  | BeiGene (Suzhou) Co., Ltd. |  | RMB480,000 |  | 10-year |  | July 28, 2032 |  | 4 |  | 64,377 |  |  | 469,900 |  |  | 58,469 |  |  | 415,000 |
Total long-term debt |  | 166,484 |  |  | 1,215,211 |  |  | 197,618 |  |  | 1,402,643 |
1.The outstanding borrowings bear floating interest rates benchmarking RMB loan interest rates of financial institutions in the PRC. The loan interest rate was 4.2% as of December 31, 2024. The Company repaid $13,739 (or RMB100,000) during the year ended December 31, 2024. The loan is secured by BeiGene Guangzhou Biologics Manufacturing Co., Ltd.’s property ownership certificate and fixed assets. 2.The outstanding borrowings bear floating interest rates benchmarking RMB loan interest rates of financial institutions in the PRC. The loan interest rate was 3.7% as of December 31, 2024. The Company repaid $8,730 (RMB62,857) during the year ended December 31, 2024. The loan is secured by Guangzhou Factory’s second land use right and certain fixed assets. 3.The outstanding borrowings bear floating interest rates benchmarking RMB loan interest rates of financial institutions in the PRC. The loan interest rate was 3.8% as of December 31, 2024. The Company repaid $5,562 (RMB40,000) during the year ended December 31, 2024. The loan is secured by fixed assets that will be placed into service upon completion of the third phase of the Guangzhou manufacturing facility’s build out. 4.The outstanding borrowings bear a floating interest rate benchmarked against prevailing interest rates of certain PRC financial institutions. The loan interest rate was 3.7% as of December 31, 2024. The Company drew down $9,053 (RMB65,000) during the year ended December 31, 2024. The loan is secured by BeiGene (Suzhou) Co., Ltd.’s property ownership certificate of the small molecule manufacturing campus in Suzhou, China. 5.The outstanding borrowings bear floating interest rates benchmarking the secured overnight financing rate. The loan interest rate was 6.2% as of December 31, 2024. $80,000 of the borrowing matures on January 27, 2025, and $300,000 matures on December 17, 2025. 6.The outstanding borrowings bear floating interest rates benchmarking RMB loan interest rates of financial institutions in the PRC. The loan interest rate was 2.6% as of December 31, 2024. 7.The outstanding borrowings bear floating interest rates benchmarking Hong Kong interbank market rate for RMB. The loan interest rate was 4.4% as of December 31, 2024.
Schedule of Contractual Maturities of Debt Obligations | The aggregate contractual maturities of all borrowings due subsequent to December 31, 2024 are as follows:
Maturity dates |  | Amounts
|  | $
Year ending December 31, 2025 |  | 851,529 |
Year ending December 31, 2026 |  | 46,207 |
Year ending December 31, 2027 |  | 46,207 |
Year ending December 31, 2028 |  | 25,657 |
Year ending December 31, 2029 |  | 19,657 |
Thereafter |  | 28,756 |
Total |  | 1,018,013 |

X
- Definition Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Subparagraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration